Retaglutide is a cutting-edge GLP-1 receptor agonist currently under study for the management of obesity. This medication works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone https://philipcobv831103.blog2learn.com/86522117/trelaglutide-exploring-a-new-therapy-for-chronic-diseases